Treme Bio
PrivateLast Round
Series B
Extension
Jan 27, 2026
Total Funding Raised
$219M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Treme Bio is a biotechnology company developing ProLymphNano, a patented drug delivery technology that focuses on the lymphatic system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treme Bio Comparables
Compare Treme Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evoq Therapeutics | 74% | |
| Ropirio Therapeutics | 69% | |
| Elicio Therapeutics | 69% | |
Treme Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 27, 2026 | ||||
| Series B | Nov 13, 2024 | ||||
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jun 22, 2021 |
Treme Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B Extension |
| Agent Capital | Series B |
| Balyasny Asset Management L.P. | Series B Extension |
| SV Health Investors | Series B Extension, Series A, Series A Extension, Series B |
| Alexandria Venture Investments | Series B Extension, Series A, Series A Extension, Series B |
| Delos Capital Partners | Series B Extension, Series B |
| Polaris Partners | Series B Extension, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
$50M raised from Alexandria Venture Investments and others.
- Nov 13, 2024
$84M round led by Delos Capital Partners.
Treme Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Treme Bio's valuation, stock price, and market status.